Cargando…

Development of a prognostic scoring system for resectable hepatocellular carcinoma

AIM: To develop a prognostic scoring system for overall survival (OS) of patients undergoing liver resection (LR) for hepatocellular carcinoma (HCC). METHODS: Consecutive patients who underwent curative LR for HCC between 2000 and 2013 were identified. The series was randomly divided into a training...

Descripción completa

Detalles Bibliográficos
Autores principales: Sposito, Carlo, Di Sandro, Stefano, Brunero, Federica, Buscemi, Vincenzo, Battiston, Carlo, Lauterio, Andrea, Bongini, Marco, De Carlis, Luciano, Mazzaferro, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037088/
https://www.ncbi.nlm.nih.gov/pubmed/27688661
http://dx.doi.org/10.3748/wjg.v22.i36.8194
_version_ 1782455662322647040
author Sposito, Carlo
Di Sandro, Stefano
Brunero, Federica
Buscemi, Vincenzo
Battiston, Carlo
Lauterio, Andrea
Bongini, Marco
De Carlis, Luciano
Mazzaferro, Vincenzo
author_facet Sposito, Carlo
Di Sandro, Stefano
Brunero, Federica
Buscemi, Vincenzo
Battiston, Carlo
Lauterio, Andrea
Bongini, Marco
De Carlis, Luciano
Mazzaferro, Vincenzo
author_sort Sposito, Carlo
collection PubMed
description AIM: To develop a prognostic scoring system for overall survival (OS) of patients undergoing liver resection (LR) for hepatocellular carcinoma (HCC). METHODS: Consecutive patients who underwent curative LR for HCC between 2000 and 2013 were identified. The series was randomly divided into a training and a validation set. A multivariable Cox model for OS was fitted to the training set. The beta coefficients derived from the Cox model were used to define a prognostic scoring system for OS. The survival stratification was then tested, and the prognostic scoring system was compared with the European Association for the Study of the Liver (EASL)/American Association for the Study of Liver Diseases (AASLD) surgical criteria by means of Harrell’s C statistics. RESULTS: A total of 917 patients were considered. Five variables independently correlated with post-LR survival: Model for End-stage Liver Disease score, hepatitis C virus infection, number of nodules, largest diameter and vascular invasion. Three risk classes were identified, and OS for the three risk classes was significantly different both in the training (P < 0.0001) and the validation set (P = 0.0002). Overall, 69.4% of patients were in the low-risk class, whereas only 37.8% were eligible to surgery according to EASL/AASLD. Survival of patients in the low-risk class was not significantly different compared with surgical indication for EASL/AASLD guidelines (77.2 mo vs 82.5 mo respectively, P = 0.22). Comparison of Harrell’s C statistics revealed no significant difference in predictive power between the two systems (-0.00999, P = 0.667). CONCLUSION: This study established a new prognostic scoring system that may stratify HCC patients suitable for surgery, expanding surgical eligibility with respect to EASL/AASLD criteria with no harm on survival.
format Online
Article
Text
id pubmed-5037088
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-50370882016-09-29 Development of a prognostic scoring system for resectable hepatocellular carcinoma Sposito, Carlo Di Sandro, Stefano Brunero, Federica Buscemi, Vincenzo Battiston, Carlo Lauterio, Andrea Bongini, Marco De Carlis, Luciano Mazzaferro, Vincenzo World J Gastroenterol Retrospective Study AIM: To develop a prognostic scoring system for overall survival (OS) of patients undergoing liver resection (LR) for hepatocellular carcinoma (HCC). METHODS: Consecutive patients who underwent curative LR for HCC between 2000 and 2013 were identified. The series was randomly divided into a training and a validation set. A multivariable Cox model for OS was fitted to the training set. The beta coefficients derived from the Cox model were used to define a prognostic scoring system for OS. The survival stratification was then tested, and the prognostic scoring system was compared with the European Association for the Study of the Liver (EASL)/American Association for the Study of Liver Diseases (AASLD) surgical criteria by means of Harrell’s C statistics. RESULTS: A total of 917 patients were considered. Five variables independently correlated with post-LR survival: Model for End-stage Liver Disease score, hepatitis C virus infection, number of nodules, largest diameter and vascular invasion. Three risk classes were identified, and OS for the three risk classes was significantly different both in the training (P < 0.0001) and the validation set (P = 0.0002). Overall, 69.4% of patients were in the low-risk class, whereas only 37.8% were eligible to surgery according to EASL/AASLD. Survival of patients in the low-risk class was not significantly different compared with surgical indication for EASL/AASLD guidelines (77.2 mo vs 82.5 mo respectively, P = 0.22). Comparison of Harrell’s C statistics revealed no significant difference in predictive power between the two systems (-0.00999, P = 0.667). CONCLUSION: This study established a new prognostic scoring system that may stratify HCC patients suitable for surgery, expanding surgical eligibility with respect to EASL/AASLD criteria with no harm on survival. Baishideng Publishing Group Inc 2016-09-28 2016-09-28 /pmc/articles/PMC5037088/ /pubmed/27688661 http://dx.doi.org/10.3748/wjg.v22.i36.8194 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Sposito, Carlo
Di Sandro, Stefano
Brunero, Federica
Buscemi, Vincenzo
Battiston, Carlo
Lauterio, Andrea
Bongini, Marco
De Carlis, Luciano
Mazzaferro, Vincenzo
Development of a prognostic scoring system for resectable hepatocellular carcinoma
title Development of a prognostic scoring system for resectable hepatocellular carcinoma
title_full Development of a prognostic scoring system for resectable hepatocellular carcinoma
title_fullStr Development of a prognostic scoring system for resectable hepatocellular carcinoma
title_full_unstemmed Development of a prognostic scoring system for resectable hepatocellular carcinoma
title_short Development of a prognostic scoring system for resectable hepatocellular carcinoma
title_sort development of a prognostic scoring system for resectable hepatocellular carcinoma
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037088/
https://www.ncbi.nlm.nih.gov/pubmed/27688661
http://dx.doi.org/10.3748/wjg.v22.i36.8194
work_keys_str_mv AT spositocarlo developmentofaprognosticscoringsystemforresectablehepatocellularcarcinoma
AT disandrostefano developmentofaprognosticscoringsystemforresectablehepatocellularcarcinoma
AT brunerofederica developmentofaprognosticscoringsystemforresectablehepatocellularcarcinoma
AT buscemivincenzo developmentofaprognosticscoringsystemforresectablehepatocellularcarcinoma
AT battistoncarlo developmentofaprognosticscoringsystemforresectablehepatocellularcarcinoma
AT lauterioandrea developmentofaprognosticscoringsystemforresectablehepatocellularcarcinoma
AT bonginimarco developmentofaprognosticscoringsystemforresectablehepatocellularcarcinoma
AT decarlisluciano developmentofaprognosticscoringsystemforresectablehepatocellularcarcinoma
AT mazzaferrovincenzo developmentofaprognosticscoringsystemforresectablehepatocellularcarcinoma